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The T-cell receptor Vfl repertoire expressed by Sez-
ary cells was determined in a series of 16 patients 
whose samples have been shown to contain a majority 
of tumor cells. By using anti-V/3 monoclonal anti-
bodies, polymerase chain reaction analysis of ex-
pressed Vf3, and, in selected cases, nucleotide se-
quencing, we have shown that the expressed Vfl 
segments belong to five Vfl families (V{35, V{36, Vf38, 
Vf313, and Vf318), which contain a large fraction of 
the T-cell receptor Vf3 repertoire and do not share 
significant similarities in complementary detennin-
S ezary syndrome is the leukemic variant of mycosis fungoides [1). Both represent forms of cutaneous T -cell lymphom a and result from proliferation of CD3 +, CD4 +, typically CD7 - mature T cells [2], which display a characteristic morphology and epidermotro-
pism. In the early stages of the disease, histopathologic and 
immunophenotypic m ethods often fail to differentiate mycosis 
fungoides/Sezary syndrome from benign cutaneous inftltrates. Fur-
th ennore, although genotypic studies of T -cell receptor (TCR) 
gene ·rea rrangem ents allow the detection of a clonal population in 
the most advanced cases (3], a polyclonal pattern is often observed 
duri.ng the ea rly stages of the disease [4] . The latter could be due to 
a low level of m alignant cells admixed with non-neoplastic poly-
clonal T cells. Alternatively, it could be explained by an initial 
phase consisting of a chronic, polyclonal T -cell expansion reactive 
to an unknown stimulus followed by a secondary transfonning 
event in some cases, then leading to a truly malignant process . 
By analogy with certain autoimmune diseases [5), tlus putative 
stimulus could be a superantigen (6) which, by interaction with 
specific TCR.s, leads to an expansion ofT cells bearing TCRs that 
display a res tri.cted V {3 repertoire. lt is therefore importan t to 
characterize the V {3 chains expressed by Sezary cells. This study is 
also of potential therapeutic interest because no definitive curative 
treatment for this severe disease currently exists and because 
preliminary reports of the treatment of T-cell lymphomas with 
monoclonal antibodies (MoAbs) directed against T -restricted anti-
gens have shown promising results [7 ,8). 
T he identification of V{3 chains expressed by Sezary cells is 
difficult beca use of the lack of a MoAb recognizing each of the 57 
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ing region 4. Vfl segments from these five families 
were also found to be strongly expressed by 
CD4+CD7- peripheral blood cells obtained by fluo-
rescence-activated cell sorting from two healthy do-
nors. The diversity of the Vf3 repertoire expressed by 
Sezary cells appears to be similar to that expressed by 
circulating non-neoplastic T cells. These data do not 
support the hypothesis that a com1non superantigen 
is involved in the initiation of this form of cutaneous 
T-celllymphoma. J Ittvest Demratol 105:56-61, 1995 
distinct V {3 segments [9 -13) . Polymerase chain reaction (PCR) 
identification of V{3 [1 4) transcription by the neoplastic cells 
represents an alternative m ethod . However, biallelic rea.rrange-
ments can occur in T ce!Js [15], and ;1dditional criteria are n eeded 
to define the functional allele (i.e ., the V{3 segment included in the 
receptor). In addition to these technica l diffi culties, the frequent 
admi.A"ing ofSezary cells with TCRa(3-expressing polyclonal T cells 
invalidates the use of strategies that do not analyze cells at the 
single-cell level. 
Predominant expression of V {38 by mycosis fLmgoides cells has 
been reported based on the analysis by MoAbs of a limited number 
of cases [1 6). T hese data were not confirmed by two more recent 
studies using reverse transcriptase-PCR [17) and l~Ase protection 
[1 8) strategies. In the former studies, however, the V {3 segments 
expressed at the cell surface of mycosis fungoides cells were not 
definitively identified [15], and in the latter, the method used 
recognized only a third of the expressed Vf3 repertoire [1 8). 
In the present study, we identified the TCR{3 chain expressed by 
Sezary cells in a series of 16 selected patients whose evaluation 
revealed a majority of Sezary cell s and a low proportion of 
polyclonal T cells (Table I) . By using an approach combining 
anti-V f3 MoAb, Vf3 family-specific reverse transcriptase-PCR and, 
in selected cases, direct nucleotide sequencing, we have identified 
the V f3 segments clonally rearranged in all 16 cases, showing that 
these segments belong to five V {3 families that do not share 
nucleotide sequence similar.i ty. We also show that thes!! fa milies, 
which contain a large fraction of the V/3 repertoire, are actively 
transcribed in non-neoplastic CD3 +CD4+CD7 - cells. These 
data, along with those reported in two of the three previously 
publ.ished series (17 , 18), suggest an umestricted use ofV {3 segments 
in Sezary syndrome and do not support th e view that activation of 
T cells by a defin ed superantigen is a consistent step in the 
oncogenic process leading to mycosis fungoides/Sezary syndrome. 
MATEIUALS AND METHODS 
Patients and Samples T he diagnosis of Sezary syndrome was based on 
standard clln.ical, morphologic , and immunophcnotypic criteria [1]. Lym-
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Table I. Patients and Cells" 
TCR 
Sezary Conftguration Cell Phenotype (% P?sitive Cells)• V/3RNA 
Cells 
Sample (%) TCR/3 TCK-y CD3 CD4 V/35.2 / 3 V/35.2 V/35.1 V/36 V/38 V12 PA NPA 
1- PBL 50 KG c 60 40 10 10 8 8 13 8 8' 
2- LN 50 RR NO 66 63 60 4 4 6 6 5 5 
3- PBL 70 RH .. NO 89 84 10 7 6 4 8 5 18 14 
4-PBL 75 RR. c 90 89 5 5 4 88 7 4 6' 
5-PBL 40 RR NO 94 84 73 3 3 4 4 4 5 
6 - PBL 33 RR c 85 82 5 6 5 10 2 8 6 
7- CYT 100 NO c 97 97 3 3 3 3 3 2 13' 
8 -PBL 30 RR c 93 91 5 3 3 4 89 3 8' 6 
9 - CYT 50 RR c 85 81 9 8 10 15 10 5 8' 
10 - CYT 30 RJl C P NO 85 5 3 4 5 5 3 8 6 
11-LI so RJ.l c 95 92 4 3 4 5 5 3 13' 12' 
12-CYT 40 NO c 89 85 6 5 5 5 6 3 5' 
13- CYT 30 IU~ c 94 90 9 7 80 9 9 7 5 
14 - CYT 25 KG c 99 99 1 1 1 1 1 2 13' 
15-PBL 17 ND ND 96 95 3 5 7 3 4 4 18 
16-CYT 16 ND NO 98 97 11 NO ND 8 6 12 5 
" PA, productive al.lcle; NI'A, nonproductive allele; P.BL, periphera l blood leukocytes; C , clonal pattern; LN, lymph node cells; ND, not done; CYT, cells obtained by 
cytaphcrcsis; CP. mLxturc of donal and polyclonal cells; Ll. cell:; from :.1 lymphoid lun g infi ltrate. R, rearranged; G, germlinc; TCR, T-ccll receptor. 
• tt should be observed that in some cases expressing a gene segment belonging to the Vl36 (patient 6) . V!l5 (patients 5, 12, 16), or Vl38 (patients 1, 9) fam ilies . the V!l chain 
was not detected by our MoAb panel. T his result suggests that these antibodies arc direc ted against cpicopcs shared by some but not all members of the corresponding V(3 f.1milies. 
r Sequenced rearrangement. 
phoid cells were obtained fro m peripheral blood by aspiration. or cytaphere-
sis, from lymph node , or, in one case, from a pleural malignan t infiltration 
(Table I). Samples were an alyzed for the presence of Sezary cells before 
further analysis. Peripheral blood lymphocytes fi-om heal thy donors were 
also used in some experiments. 
Jmmunophenotyping and Cell Sorting lmmunophenotyping of pa-
tient samples was performed by direct immunofluorescence using anti-
CD4FITC, CD3FITC (Coulter, Margency, France), and by indirect immu-
nofl uorescence with a panel of MoAbs directed against V/3 chains (T Cell 
Sciences, Cambridge, MA): 1C1 (anti V/3 5.2 + 5.3), W112 (anti V/3 5.3), 
OT145 (anti V/36.7), 16GB (anti V/38), SS11 (anti V/312), and LC4 (anti 
VJ35.1). Fluorescence patterns were analyzed on an Epics Profile cytoflu-
orom eter (Coulter). Cell sorting ofCD4 + C07- cells was perfom1ed on a 
Facs Star cell sorter (Becton Diclcinson , Sunnyvale, CA). 
TCR/3 Gene R earrangement Analysis Southern blots were performed 
as described [1 9] . BamHI- , Hi11dlii-, and EcoRl-digested DNA was hybrid-
ized with a BglTI C/3 fragment of the 4D1 TCR/3 eDNA [20] . 
PCR Analysis of Vy-Jy Junctional Sequences T he size of Vy-Jy 
junctional sequences was analyzed by e lectrophoresis on polyacrylamide 
gels after ;, vitro amplification by multiplex PCK [14] using amplimers 
directed against Vyl (primer: Vylcons), II (V-y9) , III (V-y10), and IV 
(V-y11); and J-yl, Jy2 Qy2S2) and J yPl, J yP2 QyPl/2) segm ents as 
described [21 ,22]. 
PCR Analysis of the V /3 Repertoire (Fig lD) Cells were prepared by 
gradient centrifugation on Ficoll h ypaque (Pharmacia, Uppsala, Sweden). 
Total RNA was prepared according to the m ethod of C homczyn slci and 
Sacchi [23], and 20 J.Lg of total RNA was used to synthesize a first strand 
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Figure 1.. PCR analysis of the TCR 
V/3 repertoire on ethidium bro-
mide-stained gels. Ccr, size of DNA 
fragmen ts corresponding to Ccr prod-
ucts ; V/3, size of DNA fiagrnents cor-
responding to V/3- (D/3) -J /3-C/3 prod-
ucts . A, V/3 repertoire expressed by 
peripheral blood lymphocytes from two 
healtl1y donors; B, patient 9: predomi-
nant expression of V /38 gene segments; 
C, patient with Sezary syndrome show-
ing expression of a large number ofV/3 
famili es witl1 no clear bias toward any 
of tl1cm. T his patient was not included 
in the fina l set of 16 patients. D, sche-
matic representation of tl1 e PCR strat-
egy. 
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Figure 2. Southern blots and Vy-Jy PCR. Top , representative South-
ern blots of Ba111Hl-digested genomic DNAs hybridized with a C/3 probe. 
G, gcrmline control. Patient DNAs arc indicated by their nmnbers in Table 
I. Botto111, Vy-Jy PCR experiments. P, polyclonal T-ceU DNA used as 
control; M. size marker. Patient DNAs are identified by their number. 
eDNA. The cDNAs were amplified by PCR with Vf3 and Cf3 primers using 
standard methods (40 cycles of 1 min at 92°C, 1 min at 52°C, and 2 min at 
72°C), V/3 oligonucleotides recognize sequences common to all known 
members of the 20 V (3 families initially described (except for the V {313 
primer, which contained one mismatch with one V/313 member, and the 
V/38-specific primer, which showed one and two mismatches with two 
pseudogenes, members of the V/38 fitmily) . T he location of the primers was 
chosen to amplify fragments of approximately the same size (250 to 350 base 
pairs). Their other characteristics arc described elsewhere (primer V/37 [24); 
all other primers used [25). As a control and in some cases, TCR Ca 
expression was studied simultaneously by reverse transcription-PeR (Fig 
1A). Primers used were 5'-Ca:GAACCCTGACCCTGCCGTGTACC 3'-
Ca:ATCATAAA TTCGGGTAGGATCC. An irrelevant eDNA from a non-
lymphoid line was used as a negative control for each pair of primers; 
contro ls with no eDNA added to the PCR were also perforn1ed systemat-
ically. Ten percent of each PCR product was anaiyzed by electrophoresis 
through ethidium bromide-containing agarose gels. The specificity ofPCR 
products was tested by hybridization using an oiigonucleotide internal probe 
(5 ' -GTTCCCACCCGAGGTCGCTGTG-3'), with a sequence common to 
Cf31 and C/32 constant regions of the TCR(3 locus. 
Sequencing of PCR Products Double-stranded PCR products were 
directly sequenced as described [26). 
RESULTS AND DLSCUSSION 
Patients and Selection of Samples In preliminary experi-
m en ts , we en countered problems in identifying by reverse tran-
scriptase-PCR the V(3 gen e segm ents expressed by the neoplastic 
cells (Fig 1q b ecause of the presence of a significant number of 
polyclonal T cells. It was therefore n ecessary to select patients 
whose samples con tained a high number of Sezary cells and a 
limited number of polyclonal T cells. For this purpose, from an 
initial set of 24 patients we selected 16 cases on the basis of a t least 
one of the following crite ria : 1) high percentage of Sezar y cells, 2) 
high proportion of CD4 + cells with respect to CD3 + cells, and 3) 
presence of a clearly predominant rearranged band on Southem 
blots of genomic DNA analyzed with a C(3 probe and low conten t 
of polyclonal T cells as assessed in selected cases u sing V ')'-]'y PCR 
analysis (Fig 2; Table I). 
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Figure 3. Analysis ofV/3 expression by Sezary cells from patient 8 
using im1nunophenotyping (top) and reverse transcriptase-PCR 
(bottom). The two Vf3 families 6 and 8 are strongly transcribed. As shown 
by cell-surfuce analysis with anti-Vf3 MoAb, one V/38 segment is expressed 
at tl1e protein level. 
The Functional TCR V/3 Repertoire Expressed by Sezary 
Cells Involves at Least Five Distinct Families B y assuming 
that most CD3 + cells are Sezary cells and that the CD3 complex 
expressed is associated with an a (3 heterodimer (27], we performed 
experiments to identify the V (3 rep ertoire expressed by the n eo-
plastic cells. 
The TCR. V (3 repertoire was first analyzed by ceU-surface 
expression u sing a panel of anti-V(3 MoAbs directed against one or 
more m embers from four different fa milies (V(35, 6, 8, and 12) 
(Table I; Fig 3). Using this m ethod, the V/3 expressed was 
identifi ed in o nly five of the 16 cases tested (cases 2, 4, 5, 8, and 
13). The V(38 gene family was involved in only one case, in 
contradiction to the earlier suggestion that cutaneous T - cell lym-
phoma cells predominantly express V(38 segments [16] . 
To characterize furthe r the V /3 rep ertoire of the cells, we used a 
more general V/3 family-specific reverse transcriptase-PCR ap-
proach . ln the majority of cases (cases 1 , 2, 4-7, 9, 12, 13, 15, and 
16), predominant expression of one of the 20 V (3 families tested was 
found, and V(3 could therefore reasonably be considered to be 
expressed <It the surface of the Sezary cells (Fig 1B). This was 
verified in cases 1 , 7, 9, 12, and 14 by sequencing ofPCR. pro ducts, 
which showed an in-frame Vf3(D)J junctional sequence (Fig 4). 
Because direct sequencing was performed, this sequence could only 
originate from clonal cells and could therefore be assigned to the 
Sezary cells . Direct evidence was also obtained in cases 2, 5, and 13, 
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Figure 4. Nucleotide sequences ofV{3(D{3)Jf3 junctions (patients 1, 4, 7-12, 14). TIISef, patient 11: selected PCR products analyzed on an ethidium 
bromide- stained geL The Vf3 corresponding to the primers used for PCR are indicated at the top of each lane. Ca, size of DNA fragments corresponding 
to Ca products; V/3, size of DNA fragments corresponding to V/3-(D/3)-J/3-C/3 products. 
for which consistent data were obtained by immunophenotypic and 
PCR analysis. In case 4, the results of the phenotypic study were 
consistent with the predominant transcription ofV{36 segments and 
were confirmed by direct sequencing (Table 1). 
In the last four cases (numbers 3, 8, 10, and 11), a strongly 
amplified band was obtained using amplimers specific for two V {3 
gene families, which suggests that the two TCR/3 alleles were 
rearranged and transcribed (Fig 3). In all of these cases, the results 
obtained by Southern blotting of genomic DNA using a C/3 probe 
were consistent with the suspected biallelic TCR/3 recombination. 
Because all elic exclusion is observed at the DNA level for V(D)J/3 
rearrangements [15], the TCR/3 chain expressed at the cell surface 
of clonal cells can be determined by demonstrating a corresponding 
clonal in-frame junctional sequence by direct sequencing. To verify 
that allelic exclusion indeed occurs at the DNA level in Sezary cells, 
we perfonned direct nucleotide sequencing for the two predomi-
nantly expressed families in one case (case 11). An out-of-frame 
clonal junctional sequence was demonstrated when the less abun-
dantly transcribed V/312 PCR product was analyzed, whereas an 
in-frame V/313.1 sequence was documented (Fig 4). In cases 8 and 
10, a clonal in-frame junctional nucleotide sequence was docu-
mented by direct sequencing of the more strongly transcribed 
allele. For case 8, the functional allele was determined by immu-
nophenotyping (Fig 3), confirming the involvement of V/38. 
Finally, for case 3, the V/3 segment expressed could be determined 
only tentatively on the basis of a predominant pattern of RNA 
expression. The validity of this assumption is based on the obser-
vation that the RNAs encoded by in-frame rearrangements are 
more stable than those encoded by nonproductive alleles [28]. 
The final V {3 assignment obtained for the 16 cases is shown in 
Table I. Only five of the 20 families analyzed were fow1d to be 
expressed (V/35, 6, 8, 13, and 18), and only seven were transcribed 
by the neoplastic cells (V/35, 6, 8, 12, 13 , 14, and 18). It is worth 
mentioning that V/35, V/36, and V/313 gene segments cluster 
together in the V{3locus and may have evolved by duplication form 
an ancestral cassette [13]. These V/3 families are used by at least 
30% of the circulating T cells (for discussion see [13]) . As these 
families contain the m<Uority of the currently described V {3 seg-
ments (i .e., 24 of 57 [11]), it is tempting to speculate that the 
predominant use of these V/3 families reflects their relative fre-
quency with respect to the total number of V {3 . However, it was 
not determined definitively whether this apparently restricted usage 
may be the result of some genetic mechanism or immunologic 
selection and not due to chance alone. 
Comparison of the V{3 Repertoire Expressed by Sezary 
Cells and by CD4+CD7- T Cells We reasoned that if the V/3 
pattern we observed were independent of a specific superantigen, 
then the corresponding V {3 families would be also preferentially 
expressed by T cells characterized by a differentiation stage similar 
to that of Sezary cells (i.e., mature CD4+a{3 T cells). 
Although the qualitative method we used precluded detailed 
analysis, tlus hypothesis was not excluded by inspection of the V {3 
repertoire from normal peripheral T cells (Fig tA) . To analyze tlus 
issue further and because certain differences in the use of V {3 
segn1ents have been described for CD4 and CDS cells [29], we 
selected CD4+CD7- T cells (whose phenotype is reminiscent of 
that of Sezary cells) from two healthy donors by fluorescence-
activated cell sorting, purified the corresponding l~As, and 
analyzed the transcribed V {3 repertoire by reverse transcriptase-
PCR. Both independent experiments gave consistent results; one of 
these is shown in Fig 5. All V/3 segments transcribed by Sezary cells 
(V/35, 6, 8, 12, 13, 14, and 18) were clearly transcribed in these 
cells. It is noteworthy, however, that other V/3 families were also 
strongly expressed, including V/32, 4, and 19. We have not found 
these gene segments to be expressed in our series of patients, but 
Kono e/ a/ [18] have described cases expressing these gene segment 
families . 
The Diversity of the V/3 Repertoire Expressed by Sezary 
Cells Does Not Support a Superantigen Model Tllis study 
was performed to examine the possible involvement of superanti-
gens in the pathogenesis of the Sezary syndrome. It was possible 
that some modified endogenous or exogenous superantigen ex-
pressed in the skin could drive the expansion ofT cells and act as 
a cofactor in tumor development. 
It is now well established that the TCRa/3 heterodirner recog-
nizes antigen in the context of the polymorphic products of the 
major lustocompatibility complex (MHC) genes. Two types of 
antigen recognition have been described; classic recognition in-
volves interaction between certain lughly diversified regions of the 
TCRa and {3 chains (complementary determining regions or CDR) 
with short pep tides presented in the groove of MHC class I or class 
II antigens. The diversification ofTCR involves the combinatorial 
use of variable (V), joining 0), and, in the case of TCR/3, of 
diversity (D) regions along with random alterations in the V(D)J 
junctional sequence. CDR3 is encoded by the junctional region and 
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Figure 5. TCR V{J repertoire expressed by normal CD4+CD7-
cells. A,B, bicolor phenotypic analysis of unsorted and sorted cells, 
respectively. Purity of sorting is greater than 98%. C, Corresponding Vf3 
repertoire analyzed by South em blotting ofPCR products and hybridization 
with an intemal Cf3 probe. 
is mainly involved in peptide-MHC recogrutJon. A number of 
studies have focused on different kinds of antigens, termed super-
antigens, which are presented by MHC class II molecules and 
probably interact with the CDR4 of the TCR/3 chain, eliciting a 
response in T cells, which express the same V/3 chain but diverse 
junctional TCRa/3 CDR3 sequences (6,30]. 
Only exogenous superantigens, mainly of bacterial origin, have 
been found in humans. It is conceivable, however, that modified 
self-products may be recognized as superantigens. Such a hypoth-
esis has been suggested in the pathogenesis of certain autoimmune 
diseases, such as Sjogren syndrome (31] and rheumatoid arthritis 
(5]. It has been demonstrated that certain bacterial superantigens 
stinmlate T cells bearing the V/3 chains preferentially expressed by 
inte rleukin-2 receptor expressing synoviaJ T cells from rheumatoid 
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Figu~:e 6. V{J gene segments used to encode the TCR{J chain in 
mycosis fungoides/Sezary syndrome patients. R esults from tins study 
(solid bars), those of Kono et a/ (16) (shaded l>ars), and selected cases (i .e., 
cases with only one transcribed Vf3 family) from Bahler eta/ (17] (open bm~) 
are shown. 
arthritis patients, suggesting that they may be involved in the 
pathogenesis of this disease (5] . 
Our results, together with two recent publications [17, 1 8], 
demonstrate that Sezary cells can use a large number of distinct V{3 
gene families to encode the /3 chain of the TCR (Fig 6). The V/3 
segments used do not belong to families sharing any particuiat 1 
sequence homology in the CDR4 region. These data therefore do 
not support the hypothesis of Jack et a/ [16] that a superantigen, 
common to all patients and eliciting aT-cell response independent 
of MHC haplotypes, is involved in the initiation of the disease. 
According to tlus view, different V{3 families used by Sezary cells do 
not share significant homologies in their CDR4 region. Moreover, 
it is unlikely, at least in our patients, that MHC class II haplotypes 
determine the V /3 genes expressed by the neoplastic cells. In three 
of the four patients whose cells expressed V{38 (patients 8-10), 
MHC class II haplotypes have been detenni.ned by restriction 
fragment length polymorplusm anaJysis (P. Loiseau, personal coll1-
munication) . No DR, DP, or DQ haplotype shared by ali three 
patients could be demonstrated. 
The pathogenesis of mycosis fungoides/Sezacy syndrome re-
mains unclear. The involvement of retroviruses [32 ,33] is possible, 
and conventional T -cell activation by skin-derived pep tides re-
mains an attractive hypothesis. The analysis of tlus hypothesis 
clearly requires the use of cellular methods allowing the study of 
epidennal cell/ T -cell interactions. 
T his work was supp011ed by grants from the Comte de Pmis de Ia Ligue N ationale 
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